参考文献/References:
[1] 赵化庭, 戴海龙, 光雪峰. 阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J]. 中国心血管病研究, 2015, 13(1):5-7.
[2] Gonza lMN, Troncoso-Acevedo MF, Ga-3Mez GT. Home ventilation therapy in obstructive sleep apnea-hypopnea syndrome[J]. Archivos De Bronconeumologia, 2014, 50(12):528-534.
[3] 吕纪玲, 张永发, 魏艳丽,等. 持续气道正压通气对OSAHS患者baPWV的影响[J]. 中国现代医生, 2017, 55(12):5-8.
[4] Miyaki A, Maeda S, Choi Y, et al. Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals[J]. American Journal of Hypertension, 2013, 26(10):1250.
[5] 何权瀛, 王莞尔. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)[J]. 中华全科医师杂志, 2015, 14(7):398-405.
[6] Sedkaoui K, Leseux L, Pontier S, et al. Efficiency of a phone coaching program on adherence to continuous positive airway pressure in sleep apnea hypopnea syndrome: a randomized trial[J]. Bmc Pulmonary Medicine, 2015, 15(1):1-8.
[7] De-Backer W. Obstructive sleep apnea-hypopnea syndrome[J]. Panminerva Medica, 2013, 55(2):191.
[8] Morgenthaler TI, Kuzniar TJ, Wolfe LF, et al. The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy[J]. Sleep, 2014, 37(5):927-34.
[9] 赵良平, 王学斌, 王 莉,等. 心脏内科住院患者阻塞性睡眠呼吸暂停低通气综合征的患病风险及预后的关系[J]. 中国全科医学, 2015,18(32):3918-3921.
[10] Pugalenthi AK, Thomas B, Wong P, et al. Compliance to non-invasive continuous positive airway pressure ventilation in children with obstructive sleep apnoea[J]. European Respiratory Journal,2015,46(suppl59):PA2192.
[11] Saiki A, Sato Y, Watanabe R, et al. The role of a novel arterial stiffness parameter,cardio-ankle vascular index (CAVI), as a surrogate marker for cardiovascular diseases[J].journal of atherosclerosis & Thrombosis, 2015, 23(2):155.
[12] Shirai K, Saiki A, Nagayama D, et al. The role of monitoring arterial stiffness with cardio-ankle vascular index in the control of lifestyle-related diseases[J]. Pulse, 2015, 3(2):118-133.
[13] Pelechas E, Doina A. Impact of nasal continuous positive airway pressure on heart rhythm in patients with obstructive sleep apnea/hypopnea syndrome[J]. Minerva Medica, 2014, 105(3):255-260.
[14] Hudzik B, Danikiewicz A, Szkodzinski J, et al. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation[J]. European Cytokine Network, 2014, 25(3):41-45.
[15] Kuang J. Obstructive sleep apnea-hypopnea syndrome clinical in subtypes a principal component analysis-based cluster analysis[J]. Chest, 2016, 149(4):A566-A566.
[16] Pop MA, Drugan TC, Urda A, et al. The main symptoms in dorsal sleep apnea-hypopnea syndrome[J]. Applied Medical Informatics, 2013, 33(4):1-10.
[17] Nagappa M, Mokhlesi B, Wong J, et al. The effects of continuous positive airway pressure on postoperative outcomes in obstructive sleep apnea patients undergoing surgery: A Systematic Review and Meta-analysis.[J]. Anesthesia & Analgesia, 2015, 120(5):1013-1023.
[18] 王 强.通气综合征患者外周血血管活性物质及脂肪因子水平的变化[J]. 中国药物与临床, 2017, 17(10):1472-1474.